Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Enterprise value

Enterprise value at other companies

Pfizer logo
PfizerPFE
$222.4B+9.2%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$9.52B+3.0%
Viatris logo
ViatrisVTRS
$28.36B+17.7%
Opko Health logo
Opko HealthOPK
$918.12M-21.5%
AptarGroup logo
AptarGroupATR
$9.25B-13.9%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$869.56M-27.2%

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

$888.8Mmarket cap+$686.6Mtotal debt−$170.9Mcash and equivalents=$1.4B

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's enterprise value?
Amphastar Pharmaceuticals (AMPH) reported enterprise value of $1.4B in Q1 2026.
How has Amphastar Pharmaceuticals's enterprise value changed year-over-year?
Amphastar Pharmaceuticals's enterprise value decreased by 24.1% year-over-year, from $1.85B to $1.4B.
What is the long-term trend for Amphastar Pharmaceuticals's enterprise value?
Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's enterprise value has grown at a 12.9% compound annual growth rate (CAGR), from $937.4M to $1.72B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.